Straumann Holding AG (STMN.SW) stock: Winston Score, insiders and Congress trades
Straumann is a Swiss company that makes dental implants, clear aligners, and other tools dentists use to replace missing teeth or straighten smiles. Its customers are dentists, oral surgeons, and dental clinics around the world. Straumann is one of the largest dental implant companies globally and also owns the ClearCorrect aligner brand, competing directly with Invisalign. The company earns money by selling its implants, instruments, and aligner products directly to dental professionals, with some recurring revenue from consumables and digital dentistry software. Straumann operates across Europe, North America, Asia-Pacific, and emerging markets, generating roughly CHF 2.3 billion in annual revenue. Its strong brand reputation, clinical research history, and relationships with dental schools give it a durable competitive position. The key growth driver is expanding into faster-growing markets like China and Brazil, while the main risk is pricing pressure from lower-cost implant competitors eating into its premium market share.
Winston Score: 64 out of 100, Good
A decent business — some strong pillars, some weaker.
- Quality: Exceptional (27/30)
- Growth: Weak (4/20)
- Cash Flow: Exceptional (9/10)
- Stability: Strong (7/10)
- Valuation: Good (6/10)
- Ownership: Good (10/15)
Key Facts
Price: 87.82 CHF
Market Cap: 14.0B CHF
Sector: Healthcare
Industry: Medical - Instruments & Supplies
Exchange: SIX Swiss Exchange
Editorial rules set and reviewed by Felix Prehn, Economist and Editor. Figures are refreshed daily from Financial Modeling Prep and company filings; last refreshed 2026-10-08.



